{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:38:47Z","timestamp":1778621927955,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["ZonMw\/731010011"],"award-info":[{"award-number":["ZonMw\/731010011"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","award":["V\/150013\/18\/ED"],"award-info":[{"award-number":["V\/150013\/18\/ED"]}],"id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006209","name":"Radboud University Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006209","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Monash Bioeth. Rev."],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Control measures directed at carriers of multidrug-resistant organisms are traditionally approached as a trade-off between public interests on the one hand and individual autonomy on the other. We propose to reframe the ethical issue and consider control measures directed at carriers an issue of solidarity. Rather than asking \u201cwhether it is justified to impose strict measures\u201d, we propose asking \u201chow to best care for a person\u2019s carriership and well-being in ways that do not imply an unacceptable risk for others?\u201d. A solidarity approach could include elevating baseline levels of precaution measures and accepting certain risks in cases where there is exceptionally much at stake. A generous national compensation policy that also covers for costs related to dedicated care is essential in a solidarity approach. An additional benefit of reframing the questions is that it helps to better acknowledge that being subjected to control measures is a highly personal matter.<\/jats:p>","DOI":"10.1007\/s40592-020-00119-9","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T10:03:04Z","timestamp":1604743384000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Infection control measures in times of antimicrobial resistance: a matter of solidarity"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6573-0333","authenticated-orcid":false,"given":"Babette","family":"Rump","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aura","family":"Timen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies","family":"Hulscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"issue":"2","key":"119_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jhin.2010.04.027","volume":"76","author":"C Abad","year":"2010","unstructured":"Abad, C., A. Fearday, and N. Safdar. 2010. Adverse effects of isolation in hospitalised patients: a systematic review. Journal of Hospital Infection 76 (2): 97\u2013102. https:\/\/doi.org\/10.1016\/j.jhin.2010.04.027","journal-title":"Journal of Hospital Infection"},{"issue":"6","key":"119_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","volume":"128","author":"MN Alekshun","year":"2007","unstructured":"Alekshun, M.N., and S.B. Levy. 2007. Molecular mechanisms of antibacterial multidrug resistance. Cell 128 (6): 1037\u201350. https:\/\/doi.org\/10.1016\/j.cell.2007.03.004","journal-title":"Cell"},{"issue":"5","key":"119_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ajic.2010.07.017","volume":"39","author":"C Backman","year":"2011","unstructured":"Backman, C., G. Taylor, A. Sales, and P.B. Marck. 2011. An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective. American Journal of Infectious Control 39 (5): 368\u201378.","journal-title":"American Journal of Infectious Control"},{"issue":"2","key":"119_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5172\/conu.2011.180","volume":"39","author":"RL Barratt","year":"2011","unstructured":"Barratt, R.L., R. Shaban, and W. Moyle. 2011. Patient experience of source isolation: Lessons for clinical practice. Contemporary Nurse 39 (2): 180\u201393.","journal-title":"Contemporary Nurse"},{"key":"119_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780195335842.001.0001","volume-title":"The patient as victim and vector : ethics and infectious disease","author":"MP Battin","year":"2009","unstructured":"Battin, M.P. 2009. The patient as victim and vector\u202f: ethics and infectious disease. New York: Oxford University Press."},{"key":"119_CR6","volume-title":"Principles of biomedical ethics","author":"TL Beauchamp","year":"2013","unstructured":"Beauchamp, T.L., and J.F. Childress. 2013. Principles of biomedical ethics, 7th ed. New York: Oxford University Press.","edition":"7"},{"key":"119_CR7","unstructured":"Centers for Disease Control and Prevention; US Departement of Health and Human Services. Antibiotic resistance threats in the United States. CDC report. 2013. https:\/\/wwwcdcgov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508pdf. 2013."},{"issue":"12","key":"119_CR8","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/S1473-3099(18)30296-2","volume":"18","author":"A Chatterjee","year":"2018","unstructured":"Chatterjee, A., M. Modarai, N.R. Naylor, et al. 2018. Quantifying drivers of antibiotic resistance in humans: a systematic review. The Lancet Infectious Diseases 18 (12): e368\u2013e78.","journal-title":"The Lancet Infectious Diseases"},{"issue":"4","key":"119_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jhin.2015.05.003","volume":"90","author":"CC Cohen","year":"2015","unstructured":"Cohen, C.C., B. Cohen, and J. Shang. 2015. Effectiveness of contact precautions against multidrug-resistant organism transmission in acute care: a systematic review of the literature. Journal of Hospital Infectious 90 (4): 275\u201384.","journal-title":"Journal of Hospital Infectious"},{"key":"119_CR10","unstructured":"European Centers for Disease Prevention and Control; European Medicine Agency. The bacterial challenge: time to react. 2009. https:\/\/www.cdcgov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508pdf 2013."},{"key":"119_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jcrc.2017.10.035","volume":"43","author":"AS Jarrell","year":"2018","unstructured":"Jarrell, A.S., R.M. Kruer, L.D. Berescu, P.J. Pronovost, and J.B. Trivedi. 2018. Factors associated with in-hospital mortality among critically ill surgical patients with multidrug-resistant Gram-negative infections. Journal of Critical Care 43: 321\u20136.","journal-title":"Journal of Critical Care"},{"issue":"5\u20136","key":"119_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s15010-005-5079-z","volume":"33","author":"MF Kluytmans-Vandenbergh","year":"2005","unstructured":"Kluytmans-Vandenbergh, M.F., J.A. Kluytmans, and A. Voss. 2005. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 33 (5\u20136): 309\u201313.","journal-title":"Infection"},{"issue":"4","key":"119_CR13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/cid\/cix765","volume":"66","author":"GM Knight","year":"2018","unstructured":"Knight, G.M., C. Costelloe, K.A. Murray, J.V. Robotham, R. Atun, and A.H. Holmes. 2018. Addressing the unknowns of antimicrobial resistance: quantifying and mapping the drivers of burden. Clinical Infectious Diseases 66 (4): 612\u20136.","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"119_CR14","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan, R., A. Duse, C. Wattal, et al. 2013. Antibiotic resistance\u2014the need for global solutions. The Lancet Infectious Diseases 13 (12): 1057\u201398.","journal-title":"The Lancet Infectious Diseases"},{"issue":"2","key":"119_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ajic.2008.04.257","volume":"37","author":"DJ Morgan","year":"2009","unstructured":"Morgan, D.J., D.J. Diekema, K. Sepkowitz, and E.N. Perencevich. 2009. Adverse outcomes associated with Contact Precautions: a review of the literature. American Journal of Infection Control 37 (2): 85\u201393.","journal-title":"American Journal of Infection Control"},{"issue":"4","key":"119_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1071\/HI11020","volume":"16","author":"GA Mutsonziwa","year":"2011","unstructured":"Mutsonziwa, G.A., and J. Green. 2011. Colonised and isolated: A qualitative metasynthesis of patients\u2019 experiences of being infected with multiple drug resistant organisms and subsequent isolation. Health Care-Associated Infections 16 (4): 147\u201355.","journal-title":"Health Care-Associated Infections"},{"issue":"6","key":"119_CR17","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.ajic.2014.01.027","volume":"42","author":"SJ Patel","year":"2014","unstructured":"Patel, S.J., A.P. Oliveira, J.J. Zhou, et al. 2014. Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units. American Journal of Infection Control 42 (6): 626\u201331.","journal-title":"American Journal of Infection Control"},{"issue":"3","key":"119_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhin.2016.09.010","volume":"95","author":"B Rump","year":"2017","unstructured":"Rump, B., M. De Boer, R. Reis, M. Wassenberg, and J. Van Steenbergen. 2017. Signs of stigma and poor mental health among carriers of MRSA. Journal of Hospital Infectious 95 (3): 268\u201374.","journal-title":"Journal of Hospital Infectious"},{"issue":"9","key":"119_CR19","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3201\/eid2409.171644","volume":"24","author":"B Rump","year":"2018","unstructured":"Rump, B., A. Timen, M. Hulscher, and M. Verweij. 2018. Ethics of infection control measures for carriers of antimicrobial drug-resistant organisms. Emerging Infectious Diseases 24 (9): 1609\u201316.","journal-title":"Emerging Infectious Diseases"},{"issue":"3","key":"119_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cmi.2018.10.007","volume":"25","author":"B Rump","year":"2019","unstructured":"Rump, B., A. Timen, M. Verweij, and M. Hulscher. 2019. Experiences of carriers of multidrug-resistant organisms: a systematic review. Clinical Microbiology and Infection 25 (3): 274\u20139.","journal-title":"Clinical Microbiology and Infection"},{"key":"119_CR21","unstructured":"Rump B, Kessler C, Fanoy E, Krom A, Verweij M, Van Steenbergen. Case 2: Exceptions to National MRSA Prevention Policy for a Medical Resident with Untreatable MRSA Colonization. Bookchapter in Barrett DH, Ortmann LW, Dawson A, Saenz C, Reis A, Bolan GA. Public health ethics: cases spanning the globe. New York: Springer; 2016: 191-194."},{"key":"119_CR22","doi-asserted-by":"crossref","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. American Journal of Infectious Control 2007; 35(10, Supplement 2): S165-S93.","DOI":"10.1016\/j.ajic.2007.10.006"},{"key":"119_CR23","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. American Journal of Infection Control 35(10, Supplement2): S65-S164."},{"issue":"5","key":"119_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jinf.2012.10.028","volume":"66","author":"KZ Vardakas","year":"2013","unstructured":"Vardakas, K.Z., P.I. Rafailidis, A.A. Konstantelias, and M.E. Falagas. 2013. Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: The study, the patient, the bug or the drug? Journal of Infection 66 (5): 401\u201314.","journal-title":"Journal of Infection"},{"key":"119_CR25","unstructured":"World Health Organization. Global action plan on antimicrobial resistance. Report no. WHA68\/2015\/REC\/1. Geneva: The Organization; 2015."}],"container-title":["Monash Bioethics Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40592-020-00119-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40592-020-00119-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40592-020-00119-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T14:22:01Z","timestamp":1608387721000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40592-020-00119-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":25,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["119"],"URL":"https:\/\/doi.org\/10.1007\/s40592-020-00119-9","relation":{},"ISSN":["1321-2753","1836-6716"],"issn-type":[{"value":"1321-2753","type":"print"},{"value":"1836-6716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,7]]},"assertion":[{"value":"7 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}